Clinical Trial Update: Suhexiang Pill for Acute Ischemic Stroke: A Registry Study

View source ↗

Summary

A registry study evaluating Suhexiang Pill for acute ischemic stroke is currently recruiting at Dongzhimen Hospital in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Suhexiang Pill

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Ischemic Stroke | Status: RECRUITING